Stay updated on Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    15 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed from the record history.
    Difference
    0.0%
    Check dated 2026-03-25T19:56:44.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added to the history, and the previous v3.4.2 entry was removed.
    Difference
    0.0%
    Check dated 2026-03-11T10:22:29.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history. Removed notices about government funding lapse and NIH Clinical Center operating status (Revision: v3.4.1).
    Difference
    0.3%
    Check dated 2026-02-11T01:59:54.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    A new revision (v3.4.1) was added, introducing core study sections such as Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Eligibility, Arms and Interventions, Study Status, and Study Identification, replacing the previous revision (v3.4.0).
    Difference
    0.7%
    Check dated 2026-02-03T23:52:38.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    UI and metadata changes include a new 'Show glossary' option and color-coded highlights for additions and deletions, with the footer updated to Revision: v3.4.0 and the prior v3.3.4 entry removed.
    Difference
    0.4%
    Check dated 2026-01-27T21:15:00.000Z thumbnail image
  9. Check
    115 days ago
    Change Detected
    Summary
    Added a new revision entry to the record history: Revision: v3.3.3. The HHS Vulnerability Disclosure item and Revision: v3.3.2 were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-22T23:27:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Lenvatinib vs Chemo in Endometrial Carcinoma Clinical Trial page.